Skip to Content

Tag: Ventilator


HME Newspoll

News

Philips exit: ‘Nothing fazes us anymore' 

February 16, 2024Theresa Flaherty, Managing Editor

YARMOUTH, Maine – A decision by Philips to exit a large chunk of the U.S. respiratory market will have a significant impact on the market, say 70% of respondents to a recent HME Newspoll.  Philips announced in January that it was discontinuing sales for 19 sleep and respiratory products, including oxygen concentrators and ventilators.  “There are very few big manufacturers left,” wrote one respondent. “Respironics had many high-quality products that will be...

HME NewsPoll, Oxygen Concentrator, Philips exit, Ventilator


Read Full Articlered right arrow icon

Vendors

Philips Respironics to focus on masks, other consumables in US

January 25, 2024HME News Staff

AMSTERDAM – Philips Respironics has released a list of 19 sleep and respiratory products that it will stop selling in the United States as soon as this month, including the EverFlo home oxygen system and the Trilogy EVO and EV300 home ventilators.  “We have streamlined our portfolio to enable us to focus on programs that are best suited to changing market dynamics and will most effectively serve patients and customers in the future,” the company states on its website. “In...

Home Oxygen, Philips Respironics, Respiratory, Sleep, Ventilator


Read Full Articlered right arrow icon

Also Noted

Encore leverages AI/ML 

December 5, 2023HME News Staff

LIVINGSTON, Tenn. – Encore Healthcare says its Nexus AI/ML Nexus engine, developed in partnership with a global artificial intelligence and machine learning research leader, can save $106 million cumulatively in health care costs over five years per 1,000 ventilator patients, representing a 46.7% reduction. In contrast, the company says traditional management systems save $25 million, a 10.8% reduction. “We leveraged cutting-edge analytics techniques and forecasted potential outcomes...

Artificial Intelligence (AI), Encore Healthcare, Machine learning, Ventilator


Read Full Articlered right arrow icon

Craig Douglas

Specialty Providers

Stakeholders push back against vent denial rates 

August 15, 2023Theresa Flaherty, Managing Editor

WASHINGTON – With an “absurd” denial rate as high as 86% for non-invasive ventilators for one major Medicare Advantage plan, industry stakeholders are collaborating with patient advocacy groups to elevate their concerns with CMS.  Confusion around who qualifies for NIVs vs. bi-level devices is nothing new, but recently, it’s gotten worse, says David Chandler, senior director of payer relations for AAHomecare.  “It’s escalated to what I consider...

AAHomecare, Denial Rate, Medicare Advantage, Ventilator, VGM


Read Full Articlered right arrow icon

News

In brief: MSC and Trace Medical make buys, FDA extends EUA 

March 31, 2023HME News Staff

CLEVELAND – Medical Service Company has acquired OhioHealth Home Medical Equipment in Central Ohio.  “Through its three community locations and several in-hospital offices and liaisons, OhioHealth HME supports lightning-fast discharges for the OhioHealth hospital network,” MSC stated in a press release.  MSC has also entered a long-term partnership with the OhioHealth health system, which comprises a family of 35,000 associates, physicians and volunteers, and a network...

CPAP, Emergency Use Authorization (EUA), Food & Drug Administration (FDA), Medical Service Company, Trace Medical, Ventilator


Read Full Articlered right arrow icon

Also Noted

Baxter announces vent correction 

March 14, 2023HME News Staff

DEERFIELD, Ill. – Baxter International has issued an urgent medical device correction for the Life2000 ventilation system due to the potential for patient oxygen desaturation (low blood oxygen) events that may occur under certain conditions when the system is connected with a third-party oxygen concentrator. Low oxygen saturation may lead to symptoms like shortness of breath, confusion, rapid heart rate or bluish skin. Among the most vulnerable patients, death, life-threatening events or permanent...

Baxter International, Life2000, Oxygen Concentrator, Ventilator


Read Full Articlered right arrow icon

Vendors

FDA to Philips: Improve communication on recall 

March 11, 2022HME News Staff

WASHINGTON – The U.S. Food and Drug Administration says efforts by Philips Respironics to notify patients and others of its recall of certain ventilators and CPAP and BiPAP devices and the risk of harm from the polyester-based polyurethan (PU-PUR) sound abatement foam used in those products have been “inadequate.”  The FDA on March 10 issued a notification order to Philips Respironics requiring the company to notify all device users, DME suppliers, distributors, retailers,...

CPAP, Food & Drug Administration (FDA), Philips Recall, Ventilator


Read Full Articlered right arrow icon

Frans van Houten

Vendors

Philips reports sales decline, lowers full-year outlook

October 18, 2021HME News Staff

AMSTERDAM, the Netherlands – Philips reported EUR 4.2 billion in group sales for the third quarter, a 7.6% comparable decline due to headwinds caused by global supply chain challenges and the recall of certain CPAP devices and ventilators.  The company says comparable sales decreased 39% for its Connected Care business, following, in part, a double-digit decline in Sleep & Respiratory Care in the third quarter.  “This quarter’s sales were impacted unfavorably...

CPAP Device, Philips Recall, Ventilator


Read Full Articlered right arrow icon

Also Noted

Movair launches ventilator with high-flow oxygen

October 11, 2021HME News Staff

AUSTIN, Texas - Movair, a respiratory therapy company formerly known as International Biophysics Corporation, has launched Luisa, an advanced ventilator intended for use in homes, institutions, hospitals or portable applications for both invasive and non-invasive ventilation. Luisa can be used through the FDA's Emergency Use Authorization in response to the increasing need for safe and effective ventilators. "Increased respiratory patient illness, COVID-19 and product recalls have created a critical...

Movair, Ventilator


Read Full Articlered right arrow icon

Frans van Houten

Vendors

Philips says updates are ‘imminent’

July 27, 2021Liz Beaulieu, Editor

AMSTERDAM – Philips could hear back from the U.S. Food and Drug Administration in August about its plans to replace the foam in certain CPAP devices and ventilators, based on a timeline provided during the company’s July 26 conference call to discuss financial results for the second quarter.  Philips filed "multiple packages" of CFR 806 applications for corrections and removals with the FDA in June and CEO Frans van Houten said, based on prior experience, there’s typically...

CPAP, Foam, Food & Drug Administration (FDA), Philips Recall, Ventilator


Read Full Articlered right arrow icon